Ignite Creation Date:
2025-12-24 @ 4:32 PM
Ignite Modification Date:
2026-01-04 @ 5:27 PM
Study NCT ID:
NCT05835466
Status:
RECRUITING
Last Update Posted:
2025-10-08
First Post:
2023-03-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-24
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-12
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-29
First Submit QC Date:
None
Study First Post Date:
2023-04-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-04
Last Update Post Date:
2025-10-08
Last Update Post Date Type:
ESTIMATED